Fiber can be classified as soluble or insoluble
The concept is straightforward: after reaching goal weight, reduce to a lower dose (perhaps 4mg or 8mg) that maintains appetite suppression and metabolic benefits without the full side effect profile or cost of the maximum dose
This may be related to baseline digestive resilience, faster metabolic adaptation, or simply the fact that younger participants had fewer pre-existing conditions that could compound the GI picture
Whilst the quantities are minuscule and generally harmless, individuals with impaired kidney function may theoretically have reduced capacity to eliminate this cyanide with very high doses over extended periods, though this remains largely theoretical at normal supplemental doses
Retatrutide is under clinical development as a treatment for obesity, type 2 diabetes, and related metabolic conditions such as metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as non-alcoholic fatty liver disease)